The oral antiviral agent oseltamivir [`Tamiflu'; Roche] dominated the US 'flu market throughout the 2000/2001 influenza season

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.309, 2001-01, pp. : 7-7

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A 23% market share of new prescriptions for hepatitis C in the US has been captured by Roche's antiviral agent PEG-interferon (IFN)- -2a

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 402, 2003-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Antiviral drugs for influenza: Tamiflu® past, present and future

By Laver Graeme  

Future Virology, Vol. 1, Iss. 5, 2006-09 ,pp. : 577-586

Future Medicine

Access to resources Recommend Favorite

Determination of the Antiviral Drug Oseltamivir (Tamiflu) by Adsorptive Stripping Voltammetry

By  

Current Pharmaceutical Analysis, Vol. 7, Iss. 2, 2011-05 ,pp. : 71-78

Bentham Science Publishers

Access to resources Recommend Favorite

Oseltamivir and zanamivir for flu control

By  

Inpharma, Vol. 1, Iss. 1391, 2003-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Pharmacokinetics and Dosage Recommendations for an Oseltamivir Oral Suspension for the Treatment of Influenza in Children

By Oo C.  

Pediatric Drugs, Vol. 3, Iss. 3, 2001-01 ,pp. : 229-236

Adis International

Access to resources Recommend Favorite